In combination therapy with insulin and DPP-4 inhibitor sitagliptin Study of efficacy and safety
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000009908
- Lead Sponsor
- Diabetes Center,Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Medical history of hypersensitivity to sitagliptin Age below 20years old at the time of obtaining consent Judgment of ineligibility to be a subject by the principle investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method